Blog Posts

House GOP Conference Chair Stefanik Signs on to 340B Anti-Pickpocketing Bill

House Republican conference chair Elise Stefanik (R-NY) is the most high profile sponsor of date for the bipartisan 340B Protect Act.

U.S. House GOP Conference Chair Elise Stefanik (N.Y.), the third highest-ranking House Republican, has issued a news release and tweeted about signing on as a sponsor of bipartisan legislation prohibiting pharmacy benefit managers (PBMs) and other third-party payers from paying

Read More »

Capture Cares Foundation Awards $300,000 in Grants to 340B Providers for 2021

Capture Cares is pleased to provide grantees once again with the funding that they need to enable their missions. The projects and programs that these Covered Entities wished to receive grants for are honorable and empower the community, as well as the entity to provide additional services. The 2021 Grantees announcement was made during the 340B Summer Conference on July 27.

Please Login or Become a Paid Subscriber to View this Content

Read More »

HHS Is Vetting OPA Director Applications and Apexus Is Seeking a New Senior VP For High-Profile Position

HRSA and its 340B government contractor are looking to fill two critically important positions including replacing Rear Admiral Krista Pedley who has recently been promoted from her position as OPA Director.

The federal government has started reviewing applications from individuals seeking to be the next Director of the U.S. Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA), the unit within HRSA that oversees the 340B program. Tuesday, Sept.

Read More »

“The Biggest Crisis Since 340B’s Inception:” 340B Report Leader Provides Input in New Podcast

In a new podcast, 340B Report Publisher and CEO Ted Slafsky provides input on key 340B challenges as well as some predictions.

The dispute with pharmaceutical firms over the use of contract pharmacies for 340B covered entities is the biggest crisis facing the program since its inception in the early 1990s, 340B Report CEO and Publisher Ted Slafsky tells “The Future of

Read More »

Biden Picks Academic with Hospital Connections to Run HHS Policy Shop

Robert Otto Valdez has been selected by President Biden for a key HHS policy position that impacts the 340B program.

President Biden announced last week that he plans to nominate public health expert Robert Otto Valdez to serve as U.S. Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation (ASPE).

Please Login or Become

Read More »

North Carolina Enacts PBM Oversight Law Protecting Most 340B Covered Entities

North Carolina Gov. Roy Cooper (D) recently signed into law a new bill that gives some 340B covered entities protection from so-called discriminatory reimbursement cuts and restrictive contracting terms. Photo credit: Gov. Roy Cooper's office via Twitter.

North Carolina Gov. Roy Cooper (D) signed into law yesterday a bill that imposes greater oversight of pharmacy benefit managers and protects most categories of 340B entities from so called discriminatory reimbursement and contracting practices.


Read More »

The 340B ACE Advantage: A Credential that Sets the Standard for 340B Expertise


When it comes to operating a 340B program, health systems, hospitals, and other entities that participate in the federal drug pricing program administered by HRSA have found that hiring graduates of the Apexus Advanced 340B Operations Certificate Program is helping them achieve compliance and implement a successful 340B program. 

In the five years since Apexus established the Advanced 340B Operations Certificate Program in

Read More »

House GOP Effort to Amend 340B Falls Short in Key Committee

U.S. House Energy & Commerce Republicans yesterday filed, but majority Democrats did not consider, four 340B-related amendments to crucial budget legislation.

U.S. House Energy & Commerce Republicans yesterday filed, but majority Democrats did not consider, four 340B-related amendments to budget legislation integral to enacting congressional Democrats and the Biden administration’s Build Back Better plan.

Please Login or

Read More »

In His First Public Comments, Ex-HHS Top Lawyer Stands by 340B Contract Pharmacy Advisory Opinion

Ex-HHS General Counsel Robert Charrow during a webinar yesterday defended his since-withdrawn 340B contract pharmacy advisory opinion.

Former U.S. Health and Human Services Department General Counsel Robert Charrow yesterday defended his strongly worded and colorful December 2020 advisory opinion, since vacated by a court and withdrawn by HHS, that the 340B statute unambiguously requires drug manufacturers to

Read More »
Generic selectors
Exact matches only
Search in title
Search in content